📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-ß-hydroxylase. (2020)

First Author: Brewitz L

Attributed to: RapidFire Enhancement of Mass Spectrometry Capability Across the Biosciences funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bmc.2020.115675

PubMed Identifier: 33069066

Publication URI: http://europepmc.org/abstract/MED/33069066

Type: Journal Article/Review

Volume: 28

Parent Publication: Bioorganic & medicinal chemistry

Issue: 20

ISSN: 0968-0896